Statistics for AbbVie (id:8478 ABBV)

Valuation metrics

Market cap

296.46B

Enterprise value

358.43B

Trailing P/E (ttm)

58.45

Forward P/E

13.83

PEG ratio

13.83

Price/Sales (ttm)

5.34

Price/Book (mrq)

49.15

Enterprise Value/Revenue

6.45

Enterprise Value/EBITDA

13.98

Overview

Shares outstanding

1.77B

Float

1.76B

Shares short

18.13M

% Held by insiders

0.00%

% Held by institutions

0.73%

Average volume (10 days)

8.39M

Average volume (90 days)

Price summary

52-Week low

137.65

52-Week high

207.32

52-Week change

17.34%

Beta

0.61

50-Day moving average

191.44

200-Day moving average

178.92

Dividends and splits

Forward annual dividend rate

6.20

Forward annual dividend yield

0.04

Trailing annual dividend rate

6.20%

Trailing annual dividend yield

0.04

5-Year annual dividend yield

4.16

Payout ratio

2.14

Dividend date

February 14th, 2025

Ex-dividend date

January 15th, 2025

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

9.22%

Operating margin

28.93%

Operational effectiveness

Return on assets

7.72%

Return on equity

56.41%

Income statement

Revenue (ttm)

31.40

Revenue per share (ttm)

31.40

Quarterly revenue growth (yoy)

-0.12

Gross profit (ttm)

33.90B

EBITDA

19.46B

Net income to common (ttm)

5.08B

Diluted EPS (ttm)

2.87

Quarterly earnings growth (yoy)

-12.20%

Balance sheet

Total cash (mrq)

7.29B

Total cash per share (mrq)

4.12

Total debt (mrq)

71.32B

Total Debt/Equity (mrq)

1.17K

Current ratio (mrq)

64.50%

Book value per share (mrq)

3.41

Cash flow

Cash flow statement

16.51B

Levered free cash flow (LFCF)

17.74B